Revenue · 2011–2025

Pacira Biosciences revenue

$726M+3.6% · FY2025

Pacira Biosciences (PCRX) reported $726M in revenue for fiscal 2025, +3.6% year on year.

$15.7M2011$39.1M2012$85.6M2013$198M2014$249M2015$276M2016$287M2017$337M2018$421M2019$430M2020$542M2021$667M2022$675M2023$701M2024$726M2025
Pacira Biosciences — Revenue, 2011–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$726M+3.6%Open →
FY20242024-12-31$701M+3.9%Open →
FY20232023-12-31$675M+1.2%Open →
FY20222022-12-31$667M+23.1%Open →
FY20212021-12-31$542M+26.0%Open →
FY20202020-12-31$430M+2.0%Open →
FY20192019-12-31$421M+24.8%Open →
FY20182018-12-31$337M+17.7%Open →
FY20172017-12-31$287M+3.7%Open →
FY20162016-12-31$276M+11.0%Open →
FY20152015-12-31$249M+26.0%Open →
FY20142014-12-31$198M+131.1%Open →
FY20132013-12-31$85.6M+118.9%Open →
FY20122012-12-31$39.1M+149.1%Open →
FY20112011-12-31$15.7M—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +31.5%

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Pacira Biosciences revenue |url=https://companiesranked.com/en/company/pacira-biosciences/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Pacira Biosciences revenue. CompaniesRanked. https://companiesranked.com/en/company/pacira-biosciences/revenue

BibTeX

@misc{companiesranked-en-company-pacira-biosciences-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Pacira Biosciences revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/pacira-biosciences/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001628280-26-012297 · February 26, 2026

{{cite web |title=Pacira Biosciences revenue — 10-K (0001628280-26-012297) |url=https://www.sec.gov/Archives/edgar/data/1396814/000162828026012297/pcrx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Pacira Biosciences overview